Global Antibacterial Drugs Market 2015-2019 - Key Vendors are Allergan, GlaxoSmithKline, Merck, Novartis, Pfizer & Teva Pharmaceuticals

DUBLIN, December 8, 2015 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/6kjtgs/global) has announced the addition of the"Global Antibacterial Drugs Market 2015-2019"report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The availability of funding for the development of drugs used in the treatment of diseases caused by drug resistant bacteria is providing an encouragement for more manufacturers to enter the market. Also, the strategic alliances formed between the vendors help in increased penetration of the drugs in the market and increase market share.

According to the report, the special regulatory designations provided for the development of antibiotic drugs is one of the major drivers for the growth of the market. The Generating Antibiotics Incentives Now (GAIN) Act by US FDA provides QIDP designation for pipeline molecules. This designation helps in the faster development of drugs along with eligibility for priority reviews for NDA.

Further, the report states that the development of multidrug-resistant microbes due to the irrational use of antibacterial drugs increases the severity of the infections often leading to the death of the individual. This is affecting market growth as mortality rates are increasing.

Key questions answered in this report:

• What will the market size be in 2019 and what will the growth rate be?
• What are the Key Market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Antibacterial Overview

PART 06: Pipeline analysis

PART 07: Antimicrobial resistance

PART 08: Legislation relating to antibiotic use in the US

PART 09: Market landscape

PART 10: Market segmentation by chemical class

PART 11: Market segmentation by drug origin

PART 12: Market segmentation by mechanism of action

PART 13: Market segmentation by spectrum of activity

PART 14: Geographical segmentation

PART 15: Market drivers

PART 16: Impact of drivers

PART 17: Market challenges

PART 18: Impact of drivers and challenges

PART 19: Market trends

PART 20: Vendor landscape

PART 21: Key vendor analysis

Key vendors:

• Allergan
• GlaxoSmithKline
• Merck
• Novartis
• Pfizer
• Teva Pharmaceuticals

Other Prominent Vendors:

• Abbott
• Achaogen
• Actelion
• AmpliPhi Biosciences
• Aspen Pharmacare
• Astellas
• AstraZeneca
• Aurobindo Pharma
• Baxter
• Basilea Pharmaceuticals
• Bayer
• Biocon
• Bristol-Myers Squibb
• Cempra
• Cipher Pharmaceuticals
• Corden Pharma
• Cornerstone Therapeutics
• Eli Lilly
• Exoxemis
• F. Hoffmann-La Roche
• Flynn Pharma
• Hospira
• Incepta Pharmaceuticals
• InSite Vision
• Insmed Incorporated
• Johnson & Johnson
• KaloBios Pharmaceuticals
• Kyorin Pharmaceutical
• Lupin Pharmaceuticals
• Lytix Biopharma
• Melinta Therapeutics
• Mylan
• Nektar
• Orchid Pharma
• Par Pharmaceutical
• Paratek Pharmaceuticals
• Pernix Therapeutics
• PTC Therapeutics
• RedHill Biopharma
• Sagent Pharmaceuticals
• Sanofi
• Shionogi
• Starpharma
• Sun Pharmaceutical
• Symbiomix
• Takeda Pharma
• Tetraphase Pharmaceuticals
• Theravance Biopharma
• The Medicines Company
• Valneva
• Wockhardt Global Solutions

For more information visithttp://www.researchandmarkets.com/research/6kjtgs/global

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Laura Wood
[phone]
[e-mail]